April 29th 2025
Among the new data the company plans to show in its presentations is the successful, repeated dosing of an mRNA-LNP in monkeys.
Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.
Scale up of Fed-Batch Culture to Produce Plasmid DNA in Escherichia coli (Peer Reviewed)
The authors present scale-up from a 5-L fermentor to a 50-L pilot-scale using the criterion of constant power consumption per unit liquid volume.